Mariapia Degli-Esposti
Mariapia Degli-Esposti
Verified email at
Cited by
Cited by
TRAIL‐R2: a novel apoptosis‐mediating receptor for TRAIL
H Walczak, MA Degli‐Esposti, RS Johnson, PJ Smolak, JY Waugh, ...
The EMBO journal 16 (17), 5386-5397, 1997
The novel receptor TRAIL-R4 induces NF-κB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain
MA Degli-Esposti, WC Dougall, PJ Smolak, JY Waugh, CA Smith, ...
Immunity 7 (6), 813-820, 1997
Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family
MA Degli-Esposti, PJ Smolak, H Walczak, J Waugh, CP Huang, ...
The Journal of experimental medicine 186 (7), 1165-1170, 1997
Activation of NK cell cytotoxicity
MJ Smyth, E Cretney, JM Kelly, JA Westwood, SEA Street, H Yagita, ...
Molecular immunology 42 (4), 501-510, 2005
Close encounters of different kinds: dendritic cells and NK cells take centre stage
MA Degli-Esposti, MJ Smyth
Nature Reviews Immunology 5 (2), 112-124, 2005
Functional interactions between dendritic cells and NK cells during viral infection
DM Andrews, AA Scalzo, WM Yokoyama, MJ Smyth, MA Degli-Esposti
Nature immunology 4 (2), 175-181, 2003
Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity
CE Andoniou, SLH van Dommelen, V Voigt, DM Andrews, G Brizard, ...
Nature immunology 6 (10), 1011-1019, 2005
Infection of dendritic cells by murine cytomegalovirus induces functional paralysis
DM Andrews, CE Andoniou, F Granucci, P Ricciardi-Castagnoli, ...
Nature immunology 2 (11), 1077-1084, 2001
A contribution of mouse dendritic cell–derived IL-2 for NK cell activation
F Granucci, I Zanoni, N Pavelka, SLH Van Dommelen, CE Andoniou, ...
The Journal of experimental medicine 200 (3), 287-295, 2004
Ancestral haplotypes: conserved population MHC haplotypes
MA Degli-Esposti, AL Leaver, FT Christiansen, CS Witt, LJ Abraham, ...
Human immunology 34 (4), 242-252, 1992
NK cell maturation and peripheral homeostasis is associated with KLRG1 up-regulation
ND Huntington, H Tabarias, K Fairfax, J Brady, Y Hayakawa, ...
the Journal of Immunology 178 (8), 4764-4770, 2007
Innate immunity defines the capacity of antiviral T cells to limit persistent infection
DM Andrews, MJ Estcourt, CE Andoniou, ME Wikstrom, A Khong, V Voigt, ...
Journal of Experimental Medicine 207 (6), 1333-1343, 2010
Interleukin 15–mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1
ND Huntington, H Puthalakath, P Gunn, E Naik, EM Michalak, MJ Smyth, ...
Nature immunology 8 (8), 856-863, 2007
Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells
V Voigt, CA Forbes, JN Tonkin, MA Degli-Esposti, HRC Smith, ...
Proceedings of the National Academy of Sciences 100 (23), 13483-13488, 2003
To die or not to die—the quest of the TRAIL receptors
M Degli‐Esposti
Journal of leukocyte biology 65 (5), 535-542, 1999
β‐glucan triggers spondylarthritis and Crohn's disease–like ileitis in SKG mice
M Ruutu, G Thomas, R Steck, MA Degli‐Esposti, MS Zinkernagel, ...
Arthritis & rheumatism 64 (7), 2211-2222, 2012
A new polymorphic and multicopy MHC gene family related to nonmammalian class I
C Leelayuwat, MA Degli-Esposti, LJ Abraham, RL Dawkins, DC Townend
Immunogenetics 40 (5), 339-351, 1994
Activation of natural killer (NK) T cells during murine cytomegalovirus infection enhances the antiviral response mediated by NK cells
SLH Van Dommelen, HA Tabarias, MJ Smyth, MA Degli-Esposti
Journal of virology 77 (3), 1877-1884, 2003
Perforin and granzymes have distinct roles in defensive immunity and immunopathology
SLH van Dommelen, N Sumaria, RD Schreiber, AA Scalzo, MJ Smyth, ...
Immunity 25 (5), 835-848, 2006
The murine cytomegalovirus chemokine homolog, m131/129, is a determinant of viral pathogenicity
P Fleming, N Davis-Poynter, M Degli-Esposti, E Densley, J Papadimitriou, ...
Journal of virology 73 (8), 6800-6809, 1999
The system can't perform the operation now. Try again later.
Articles 1–20